Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients
Elhommosani, Mahetab R; Sakr, Masarra M; Abbas, Rania M; Aboshanab, Khaled;
Abstract
The extensive variability and conflicting information in Coronavirus Disease 2019 (COVID-19) patient data have made it difficult for the medical community to gain a comprehensive understanding and develop clear, reliable guidelines for managing COVID-19 cases. As the world uncovers the diverse side effects of the pandemic, the pursuit of knowledge about COVID-19 has become crucial. The present study aimed to evaluate some clinically relevant serum proteins, providing analysis of the obtained results to employ them in the diagnosis, prognosis, and disease monitoring among COVID-19 patients.
Other data
| Title | Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients | Authors | Elhommosani, Mahetab R; Sakr, Masarra M ; Abbas, Rania M; Aboshanab, Khaled | Keywords | Acute kidney impairment;Acute liver injury;Alanine transaminase;Aspartate transaminase;COVID-19;D-dimer;End-organ damage;Ferritin;Interleukin-6;Procalcitonin;Serum creatinine | Issue Date | 20-Feb-2024 | Journal | BMC infectious diseases | ISSN | 1471-2334 | DOI | 10.1186/s12879-024-09113-6 | PubMed ID | 38378528 | Scopus ID | 2-s2.0-85185472091 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.